Asian Subgroup Analysis of the REMISSIO Study: A Long-Term Efficacy and Safety Study of Paliperidone Palmitate 3-month Formulation in Patients with Stable Schizophrenia in a Naturalistic Clinical Setting

OBJECTIVE: To evaluate the long-term efficacy and safety of three-monthly paliperidone palmitate (PP3M) in Asian patients with stable schizophrenia in a naturalistic setting. METHODS: Asian patients recruited between May 2016 and March 2018 from the prospective, single-arm, non-randomized, open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Young-Chul, Yang, Yen Kuang, Sulaiman, Ahmad Hatim, Bergmans, Paul, Tan, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329113/
https://www.ncbi.nlm.nih.gov/pubmed/35879027
http://dx.doi.org/10.9758/cpn.2022.20.3.427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329113/
https://www.ncbi.nlm.nih.gov/pubmed/35879027
http://dx.doi.org/10.9758/cpn.2022.20.3.427

Ejemplares similares